Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Usana Health Sciences Inc

NYSE: USNA · Life Sciences · 3 alerts · CIK 896264

Share price
$13.54Close, Nov 16
Market cap
$250M
Shares outstanding
18.49MLatest SEC cover page
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Usana Health Sciences Inc filings on SEC EDGAR ↗

1:56 PM ET 10-Q
Financial Results

Usana Health Sciences Q3 2026 Results: Net Loss of $5.56M, Loss Narrows

USANA Health Sciences is transitioning to an omni-channel health and wellness model following the acquisitions of Hiya Health Products and Rise Wellness. The company reports a decline in net sales and active customers in its Core Nutritional direct-selling business, particularly in China, while facing macroeconomic pressures and volatile foreign currency fluctuations.

Key figure
Net loss $5.56M
4:11 PM ET 8-K
Financial Results

Usana Health Sciences Financial Results

USANA Health Sciences reported third quarter 2026 net sales of $206 million and a net loss of $5.6 million. While Core Nutritional active customers declined year-over-year, the company saw an 18% sequential increase in Hiya active monthly subscribers and generated $36 million in year-to-date free cash flow.

Term
Q3 2026

“As we continue our transformation to an omnichannel health and wellness company, our third quarter results were mixed, with meaningful improvement in some areas and results that fell short of our expectations in others.”

Kevin Guest, Chairman and Chief Executive Officer

“In Core Nutritional, rebuilding our active customer base is our top priority and our single largest growth lever.”

Kevin Guest, Chairman and Chief Executive Officer
4:36 PM ET 8-K
Loan & Debt

Usana Health Sciences $75M Debt Financing with Bank of America, N.A.

USANA Health Sciences entered into a first amendment to its $75 million revolving credit facility with Bank of America. The amendment modifies financial covenants, including a minimum consolidated EBITDA requirement of $100 million, and increases the annual limit for general asset disposals to $2.5 million. It also specifically permits the sale and potential leaseback of the company's real property in Sydney, Australia.

Value
$75M
Counterparty
Bank of America, N.A.
Term
through June 2030

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.